|
|
Volumn 18, Issue 7, 2009, Pages 424-428
|
|
Adverse events in bevacizumab and chemotherapy: patient management.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
BLEEDING;
BREAST TUMOR;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
DRUG APPROVAL;
DRUG EFFECT;
DRUG MONITORING;
HUMAN;
INTESTINE PERFORATION;
METHODOLOGY;
NURSE ATTITUDE;
NURSING;
NURSING ASSESSMENT;
ONCOLOGY NURSING;
PATIENT CARE PLANNING;
PRACTICE GUIDELINE;
PROTEINURIA;
REVIEW;
SAFETY;
WOUND HEALING;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARDIOVASCULAR DISEASES;
DRUG APPROVAL;
DRUG MONITORING;
HEMORRHAGE;
HUMANS;
INTESTINAL PERFORATION;
NURSE'S ROLE;
NURSING ASSESSMENT;
ONCOLOGIC NURSING;
PATIENT CARE PLANNING;
PRACTICE GUIDELINES AS TOPIC;
PROTEINURIA;
SAFETY MANAGEMENT;
WOUND HEALING;
|
|
EID: 67649674693
PISSN: 09660461
EISSN: None
Source Type: Journal
DOI: 10.12968/bjon.2009.18.7.41657 Document Type: Review |
|
Times cited : (10)
|
|
References (17)
|
